Clinical Trial

A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C

Name: A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C — clinical trial record (NCT07312773)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated December 31, 2025 (before its estimated February 7, 2026 completion). Its status may not reflect the trial's current state.

Summary

To evaluate the pharmacokinetic interactions of AD-231A, AD-231B, and AD-231C in healthy adult volunteers.

Trial Details

NCT Number	NCT07312773
Lead Sponsor	Addpharma Inc.
Conditions	Hypertension, Hyperlipidemia
Enrollment	55 participants
Start Date	2026-01-23
Primary Completion	2026-02-07 (estimated)
Study Completion	2026-02-22 (estimated)
Updated on ClinicalTrials.gov	2025-12-31